Company

CamGene Therapeutics

Biotechnology Research Cambridge, Cambridgeshire, United Kingdom 3 employees

Employees: 3

www.camgenetx.com LinkedIn

CamGene Therapeutics Overview

Headquarters: Cambridge, Cambridgeshire, United Kingdom
Website: www.camgenetx.com
Industry: Biotechnology Research
Employees: 3
Founded: 2024
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

mRNA hearing loss lipid nanoparticles LNP

About CamGene Therapeutics

The WHO predicts hearing loss will impact 1 in 10 people by 2050. Medical devices are the standard of care, but they are ineffective for many people. Despite a prevalence greater than cancer or diabetes, there are currently no treatments available to treat the underlying cellular dysfunction which is the root cause of hearing loss. Lipid nanoparticle-based mRNA therapeutics were spectacularly validated as a mass market medicine through the COVID-19 pandemic. We believe the time is now to create the world’s first mass market medicine for hearing loss.